HESA Committee Meeting
Notices of Meeting include information about the subject matter to be examined by the committee and date, time and place of the meeting, as well as a list of any witnesses scheduled to appear. The Evidence is the edited and revised transcript of what is said before a committee. The Minutes of Proceedings are the official record of the business conducted by the committee at a sitting.
For an advanced search, use Publication Search tool.
If you have any questions or comments regarding the accessibility of this publication, please contact us at accessible@parl.gc.ca.
Minutes of Proceedings
Bloc Québécois
NDP
The witnesses made statements and answered questions.
On motion of Don Davies, it was agreed, — That the proposed budget in the amount of $2,000, for the study of the Main Estimates 2023-24: Votes 1 and 5 under Canadian Food Inspection Agency, Votes 1 and 5 under Canadian Institutes of Health Research, Votes 1, 5 and 10 under Department of Health, Vote 1 under Patented Medicine Prices Review Board and Votes 1, 5 and 10 under Public Health Agency of Canada, be adopted.
On motion of Don Davies, it was agreed, — That the proposed budget in the amount of $9,700, for the study of Bill C-252, An Act to amend the Food and Drugs Act (prohibition of food and beverage marketing directed at children), be adopted.
On motion of Don Davies, it was agreed, — That the proposed budget in the amount of $9,950, for the study of Bill S-203, An Act respecting a federal framework on autism spectrum disorder, be adopted.
On motion of Laila Goodridge, it was agreed, — That, in relation to Bill C-252, An Act to amend the Food and Drugs Act (prohibition of food and beverage marketing directed at children), the deadline for the submission of amendments to the clerk of the committee be no later than 12:00 p.m. on Friday, March 24, 2023.
By unanimous consent, on motion of Mike Lake, it was agreed, — That the preamble, the long title and all clauses of Bill S-203, An Act respecting a federal framework on autism spectrum disorder be adopted on division, without amendment, and that the Chair report the Bill to the House.
On motion of Don Davies, it was agreed, — That the committee hold two meetings in relation to the study of the Patented Medicine Prices Review Board among the following dates: Tuesday, April 25, 2023, Thursday, April 27, 2023, Tuesday, May 2, 2023, Thursday, May 4, 2023, Tuesday, May 9, 2023, and Thursday, May 11, 2023.
At 12:53 p.m., the committee adjourned to the call of the Chair.